Skip to content

3Accepted Oct 22, 7:20 PM ET

Versant Venture Capital VII, L.P. 3

LYCALycia Therapeutics, Inc.

Accepted (ET)

7:20 PM

Oct 22, 2026

Filed

Oct 22, 2026

Documents

1

Size

16.3 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.